HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicola R Sibson Selected Research

Demyelinating Diseases (Demyelinating Disease)

4/2014Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicola R Sibson Research Topics

Disease

17Neoplasm Metastasis (Metastasis)
04/2023 - 04/2012
16Neoplasms (Cancer)
01/2022 - 04/2012
10Brain Neoplasms (Brain Tumor)
01/2022 - 04/2012
10Inflammation (Inflammations)
01/2022 - 02/2004
8Multiple Sclerosis
09/2015 - 11/2002
4Breast Neoplasms (Breast Cancer)
01/2022 - 11/2016
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2015 - 04/2009
4Encephalitis (Encephalitis, Rasmussen)
01/2011 - 11/2002
3Neoplasm Micrometastasis
01/2022 - 04/2012
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2021 - 06/2010
3Neuroinflammatory Diseases
01/2020 - 05/2014
3Hypersensitivity (Allergy)
09/2014 - 04/2009
3Cerebral Malaria
01/2011 - 11/2002
2Hypoxia (Hypoxemia)
01/2021 - 01/2011
2Melanoma (Melanoma, Malignant)
01/2021 - 01/2015
2Stroke (Strokes)
11/2019 - 01/2017
2Disease Progression
06/2014 - 06/2004
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2014 - 05/2014
2Brain Ischemia (Cerebral Ischemia)
01/2011 - 06/2010
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2024
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2021
1Cognitive Dysfunction
01/2021
1Ischemic Stroke
01/2021
1Adenocarcinoma of Lung
01/2021
1Squamous Cell Carcinoma of Head and Neck
01/2019
1Relapsing-Remitting Multiple Sclerosis
12/2017
1Neuromyelitis Optica (Devic's Disease)
12/2017
1Schizophrenia (Dementia Praecox)
01/2017
1Hypercapnia
01/2017
1Alkalosis
11/2016
1Glioma (Gliomas)
01/2016
1Chronic Progressive Multiple Sclerosis
10/2014
1Demyelinating Diseases (Demyelinating Disease)
04/2014
1Chronic Disease (Chronic Diseases)
04/2014
1Carcinoma (Carcinomatosis)
02/2014

Drug/Important Bio-Agent (IBA)

9Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2022 - 10/2007
6Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2014
6GadoliniumIBA
01/2020 - 12/2011
6LigandsIBA
11/2019 - 10/2007
5ferric oxide (iron oxide)IBA
01/2020 - 10/2007
4Proteins (Proteins, Gene)FDA Link
01/2020 - 02/2014
4Contrast MediaIBA
11/2016 - 02/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 11/2002
3CytokinesIBA
05/2013 - 03/2008
2SynucleinsIBA
02/2024 - 11/2011
2Trastuzumab (Herceptin)FDA Link
01/2022 - 11/2013
2APTIBA
01/2021 - 01/2019
2AmidesIBA
01/2021 - 01/2019
2Protons (Proton)IBA
01/2021 - 01/2019
2Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
01/2021 - 04/2014
2AntibodiesIBA
11/2019 - 12/2017
2Myelin-Oligodendrocyte GlycoproteinIBA
12/2017 - 04/2009
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2016 - 04/2014
2Serotonin (5 Hydroxytryptamine)IBA
07/2014 - 01/2013
2Integrin alpha4beta1 (VLA-4)IBA
04/2014 - 10/2007
2Messenger RNA (mRNA)IBA
06/2013 - 11/2011
2LipopolysaccharidesIBA
01/2013 - 11/2011
1IronIBA
04/2023
1Gadolinium DTPA (Magnevist)FDA Link
01/2022
1Macrophage Colony-Stimulating FactorIBA
01/2022
1pimonidazoleIBA
01/2021
1fluoromisonidazoleIBA
01/2021
1alovudineIBA
01/2021
1Ciliary Neurotrophic Factor (CNTF)IBA
12/2020
1WP1066IBA
12/2020
1Arginine (L-Arginine)FDA Link
11/2019
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2019
1VitronectinIBA
11/2019
1Aspartic Acid (Aspartate)FDA Link
11/2019
1Immunoglobulin G (IgG)IBA
01/2019
1Radioisotopes (Radionuclides)IBA
01/2018
1Glutathione (Reduced Glutathione)IBA
01/2017
1Liposomes (Liposome)IBA
01/2017
1Dinoprostone (PGE2)FDA Link
01/2017
1Vasodilator Agents (Vasodilators)IBA
01/2017
1CalciumIBA
01/2017
1Clodronic Acid (Clodronate)IBA
01/2017
1Bovine Serum AlbuminIBA
11/2016
1Perchloric AcidIBA
11/2016
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
08/2016
1Transcription Factors (Transcription Factor)IBA
01/2016
1CateninsIBA
11/2014
1Superoxide Dismutase-1IBA
06/2014
1GlucocorticoidsIBA
06/2014
1E-SelectinIBA
04/2014
1IntegrinsIBA
04/2014
1Fingolimod Hydrochloride (FTY720)FDA Link
04/2014
1AcidsIBA
11/2013
1Lymphotoxin-alpha (Lymphotoxin)IBA
11/2013
1Type I Tumor Necrosis Factor ReceptorsIBA
11/2013

Therapy/Procedure

16Therapeutics
01/2022 - 06/2004
4Radiotherapy
01/2021 - 03/2013
2Intravenous Administration
01/2022 - 01/2015
2Immunotherapy
01/2018 - 03/2013
1Intravenous Injections
01/2022
1Image-Guided Radiotherapy
01/2021
1Radioimmunotherapy
01/2021
1Cannula
07/2017
1Cell- and Tissue-Based Therapy (Cell Therapy)
09/2014